PDE3 — Drug Target

2 drugs 1 marketed 1 in Phase 3

All drugs that target PDE3 — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Phosphodiesterase 3 (PDE3) inhibitor · PDE3 inhibitor

Marketed (1)

FosD · AstraZeneca · Phosphodiesterase 3 (PDE3) inhibitor · Cardiovascular
FosD is a phosphodiesterase 3 (PDE3) inhibitor that increases intracellular cAMP levels to promote vasodilation and improve cardiac contractility.

Phase 3 pipeline (1)

BT-KTM-I · Chengdu Brilliant Pharmaceutical Co., Ltd. · PDE3 inhibitor · Cardiovascular
BT-KTM-I is a small molecule that targets the PDE3 enzyme.